# Bionomics (stock symbol: BNOX) Logo in transparent PNG and SVG formats

## Bionomics Logo large

### Bionomics Logo large Download PNG (44.21 KB)

![Bionomics Logo large Download PNG (44.21 KB)](/img/orig/BNOX_BIG-cadfeb23.png)

### Bionomics Logo large Download SVG (5.34 KB)

![Bionomics Logo large Download SVG (5.34 KB)](/img/orig/BNOX_BIG-06c02300.svg)

## Bionomics Logo icon format

### Bionomics Logo icon format Download PNG (38.73 KB)

![Bionomics Logo icon format Download PNG (38.73 KB)](/img/orig/BNOX-d299cb4c.png)

### Bionomics Logo icon format Download SVG (882 Bytes)

![Bionomics Logo icon format Download SVG (882 Bytes)](/img/orig/BNOX-3de32724.svg)

## Bionomics Logo large for dark backgrounds

### Bionomics Logo large for dark backgrounds Download PNG (45.24 KB)

![Bionomics Logo large for dark backgrounds Download PNG (45.24 KB)](/img/orig/BNOX_BIG.D-00a576f4.png)

### Bionomics Logo large for dark backgrounds Download SVG (5 KB)

![Bionomics Logo large for dark backgrounds Download SVG (5 KB)](/img/orig/BNOX_BIG.D-f9029fd9.svg)

## Bionomics Logo icon format for dark backgrounds

### Bionomics Logo icon format for dark backgrounds Download PNG (38.05 KB)

![Bionomics Logo icon format for dark backgrounds Download PNG (38.05 KB)](/img/orig/BNOX.D-ed9ae082.png)

### Bionomics Logo icon format for dark backgrounds Download SVG (882 Bytes)

![Bionomics Logo icon format for dark backgrounds Download SVG (882 Bytes)](/img/orig/BNOX.D-b139b193.svg)

## About Bionomics

Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which is in phase 2 clinical trial for the treatment of social anxiety disorder and phase 2b to treat post-traumatic stress disorder. It also develops BNC101, a monoclonal antibody that has completed phase 1 clinical trial that targets cancer stem cells; and BNC105, which is in phase 2 clinical trial for the treatment of refractory colorectal cancer and phase 1 clinical trial for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia. Bionomics Limited was incorporated in 1996 and is based in Eastwood, Australia.

1. Website domain: bionomics.com.au
2. Marketcap: $20.51 Million USD


## Categories
- [x] ðŸ‡¦ðŸ‡º Australia
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
